RBM10 and pancreatic adenocarcinoma: Using data from PAAD patients in the TCGA database, RBM10 expression was found to be associated with patients' T stage, clinical stage, and age (all P < 0.05) (Figure 1D-F), but not with lymph node metastasis, distant metastasis, or sex (Figure S1).